PAX5-JAK2-IRES-EGFP-LUC
(Plasmid
#256278)
-
PurposeExpression of human PAX5-JAK2 fusion protein and a EGFP-LUC reporter
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 256278 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backboneMIGR1
-
Vector typeMammalian Expression, Retroviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
PAX5-JAK2-IRES-EGFP-LUC was a gift from Martin Carroll (Addgene plasmid # 256278 ; http://n2t.net/addgene:256278 ; RRID:Addgene_256278) -
For your References section:
Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL. Hurtz C, Wertheim GB, Loftus JP, Blumenthal D, Lehman A, Li Y, Bagashev A, Manning B, Cummins KD, Burkhardt JK, Perl AE, Carroll M, Tasian SK. J Clin Invest. 2020 Jul 1;130(7):3637-3653. doi: 10.1172/JCI134424. 10.1172/JCI134424 PubMed 32191635